Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122711085 | 12271108 | 5 | F | 20160408 | 20160824 | 20160415 | 20160831 | EXP | US-PFIZER INC-2016213100 | PFIZER | 64.00 | YR | F | Y | 58.60000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122711085 | 12271108 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | A563501 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
| 122711085 | 12271108 | 2 | C | WARFARIN | WARFARIN | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 122711085 | 12271108 | 3 | C | FOLIC ACID. | FOLIC ACID | 1 | 1000 MG, 1X/DAY | 0 | 1000 | MG | QD | ||||||||
| 122711085 | 12271108 | 4 | C | CITRACAL | CALCIUM CITRATE | 1 | 1000 MG, 1X/DAY | 0 | 1000 | MG | QD | ||||||||
| 122711085 | 12271108 | 5 | C | VITAMIN C | ASCORBIC ACID | 1 | 1000 MG, 1X/DAY | 0 | 1000 | MG | QD | ||||||||
| 122711085 | 12271108 | 6 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | ||||||||
| 122711085 | 12271108 | 7 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 DF, UNK (1 PUFF) | 0 | 1 | DF | NASAL SPRAY | ||||||||
| 122711085 | 12271108 | 8 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 1 DF, DAILY (1 SPRAY IN EACH NOSTIL) | 0 | 1 | DF | NASAL SPRAY | |||||||
| 122711085 | 12271108 | 9 | C | LORATADINE. | LORATADINE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 122711085 | 12271108 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | UNK, 2X/DAY (VIA NEBULIZER) | 0 | BID | |||||||||
| 122711085 | 12271108 | 11 | C | OXYCODONE | OXYCODONE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 122711085 | 12271108 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 20 MG, DAILY (5MG TAB, 4 TAB DAILY FOR 3 WEEKS) | 0 | 20 | MG | TABLET | ||||||||
| 122711085 | 12271108 | 13 | C | PREDNISONE. | PREDNISONE | 1 | 12.5 MG, DAILY (2 1/2 TAB DAILY) | 0 | 12.5 | MG | TABLET | ||||||||
| 122711085 | 12271108 | 14 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 122711085 | 12271108 | 15 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 122711085 | 12271108 | 16 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | 0 | |||||||||||
| 122711085 | 12271108 | 17 | C | LORAZEPAM. | LORAZEPAM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122711085 | 12271108 | 1 | Pulmonary hypertension |
| 122711085 | 12271108 | 2 | Thrombosis |
| 122711085 | 12271108 | 7 | Dyspnoea |
| 122711085 | 12271108 | 8 | Hypersensitivity |
| 122711085 | 12271108 | 9 | Dyspnoea |
| 122711085 | 12271108 | 10 | Dyspnoea |
| 122711085 | 12271108 | 11 | Back pain |
| 122711085 | 12271108 | 12 | Lung infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122711085 | 12271108 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122711085 | 12271108 | Liver disorder | |
| 122711085 | 12271108 | Malaise | |
| 122711085 | 12271108 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122711085 | 12271108 | 1 | 2000 | 0 |